NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹126 Cr | ₹104 Cr | ₹108 Cr | ₹83 Cr | ₹38 Cr |
What is the latest Net Current Assets ratio of NGL FINECHEM ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹126 Cr |
Mar2023 | ₹104 Cr |
Mar2022 | ₹108 Cr |
Mar2021 | ₹83 Cr |
Mar2020 | ₹38 Cr |
How is Net Current Assets of NGL FINECHEM Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹126 Cr | 20.81 | |
Mar2023 | ₹104 Cr | -3.22 | |
Mar2022 | ₹108 Cr | 30.30 | |
Mar2021 | ₹83 Cr | 118.82 | |
Mar2020 | ₹38 Cr | - |
Compare Net Current Assets of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹1,141.8 Cr | 11.1% | 5.2% | -12.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,699.0 Cr | 0.6% | -4.6% | 20.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,584.0 Cr | 9.8% | 4.5% | 64.7% | Stock Analytics | |
CIPLA | ₹116,022.0 Cr | -2.9% | -3.9% | 1.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,463.0 Cr | 0.9% | -10.4% | 0.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,434.8 Cr | 0.9% | -0.3% | 27.9% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | 11.1% |
5.2% |
-12.2% |
SENSEX | 2% |
0.1% |
8.6% |
You may also like the below Video Courses